{
  "CB1": {
    "name": "CB1",
    "type": "checkbox",
    "page": 2,
    "field_label": "Start of treatment",
    "question": "Is this request for the start of a new treatment for the patient?",
    "context": "Initial checkbox in treatment timeline section indicating whether patient is beginning new therapy."
  },
  "T2": {
    "name": "T2",
    "type": "text",
    "page": 2,
    "field_label": "Start date: (MM)",
    "question": "What is the two-digit month for the treatment start date?",
    "context": "Month component for the planned medication initiation date in treatment scheduling section."
  },
  "T3": {
    "name": "T3",
    "type": "text",
    "page": 2,
    "field_label": "Start date: (DD)",
    "question": "What is the two-digit day for the treatment start date?",
    "context": "Day component for the planned medication initiation date in treatment scheduling section."
  },
  "T4": {
    "name": "T4",
    "type": "text",
    "page": 2,
    "field_label": "Start date: (YYYY)",
    "question": "What is the four-digit year for the treatment start date?",
    "context": "Year component for the planned medication initiation date in treatment scheduling section."
  },
  "CB5": {
    "name": "CB5",
    "type": "checkbox",
    "page": 2,
    "field_label": "Continuation of therapy",
    "question": "Is this request for the continuation of an existing therapy for the patient?",
    "context": "Checkbox indicating if the request is for ongoing treatment, as opposed to new initiation."
  },
  "T6": {
    "name": "T6",
    "type": "text",
    "page": 2,
    "field_label": "Date of last treatment: (MM)",
    "question": "What is the two-digit month of the patient's last treatment?",
    "context": "Month component for the last treatment date, required for continuation of therapy requests."
  },
  "T7": {
    "name": "T7",
    "type": "text",
    "page": 2,
    "field_label": "Date of last treatment: (DD)",
    "question": "What is the two-digit day of the patient's last treatment?",
    "context": "Day component for the last treatment date, required for continuation of therapy requests."
  },
  "T8": {
    "name": "T8",
    "type": "text",
    "page": 2,
    "field_label": "Date of last treatment: (YYYY)",
    "question": "What is the four-digit year of the patient's last treatment?",
    "context": "Year component for the last treatment date, required for continuation of therapy requests."
  },
  "T9": {
    "name": "T9",
    "type": "text",
    "page": 2,
    "field_label": "Precertification Requested By:",
    "question": "Who is submitting this precertification request?",
    "context": "Identifies the individual or entity responsible for submitting the prior authorization request."
  },
  "T10": {
    "name": "T10",
    "type": "text",
    "page": 2,
    "field_label": "Phone:",
    "question": "What is the phone number of the person requesting precertification?",
    "context": "Contact phone number for follow-up regarding the submitted precertification request."
  },
  "T11": {
    "name": "T11",
    "type": "text",
    "page": 2,
    "field_label": "Fax:",
    "question": "What is the fax number of the person requesting precertification?",
    "context": "Contact fax number for sending or receiving precertification-related documents."
  },
  "T12": {
    "name": "T12",
    "type": "text",
    "page": 5,
    "field_label": "Patient First Name",
    "question": "What is the patient's first name?",
    "context": "Patient demographic information for identification purposes in the clinical information section."
  },
  "T13": {
    "name": "T13",
    "type": "text",
    "page": 5,
    "field_label": "Patient Last Name",
    "question": "What is the patient's last name?",
    "context": "Patient demographic information for identification purposes in the clinical information section."
  },
  "T14": {
    "name": "T14",
    "type": "text",
    "page": 5,
    "field_label": "Patient DOB (MM/DD/YYYY)",
    "question": "What is the patient's date of birth?",
    "context": "Patient demographic information for identification and age verification purposes."
  },
  "T15": {
    "name": "T15",
    "type": "text",
    "page": 2,
    "field_label": "Address:",
    "question": "What is the patient's home address?",
    "context": "Patient's residential street address for contact and demographic records."
  },
  "T16": {
    "name": "T16",
    "type": "text",
    "page": 2,
    "field_label": "City:",
    "question": "What is the patient's home city?",
    "context": "Patient's city of residence, part of the complete home address."
  },
  "T17": {
    "name": "T17",
    "type": "text",
    "page": 2,
    "field_label": "State:",
    "question": "What is the patient's home state?",
    "context": "Patient's state of residence, part of the complete home address."
  },
  "T18": {
    "name": "T18",
    "type": "text",
    "page": 2,
    "field_label": "ZIP:",
    "question": "What is the patient's home ZIP code?",
    "context": "Patient's ZIP code, completing the demographic home address details."
  },
  "T19": {
    "name": "T19",
    "type": "text",
    "page": 5,
    "field_label": "Patient Phone",
    "question": "What is the patient's phone number?",
    "context": "Patient contact information for communication regarding the prior authorization request."
  },
  "T20": {
    "name": "T20",
    "type": "text",
    "page": 2,
    "field_label": "Work Phone:",
    "question": "What is the patient's work phone number?",
    "context": "Patient's alternative work contact number, if applicable, for communication."
  },
  "T21": {
    "name": "T21",
    "type": "text",
    "page": 2,
    "field_label": "Cell Phone:",
    "question": "What is the patient's cell phone number?",
    "context": "Patient's mobile contact number, important for direct communication."
  },
  "T22": {
    "name": "T22",
    "type": "text",
    "page": 2,
    "field_label": "E-mail:",
    "question": "What is the patient's email address?",
    "context": "Patient's email address for electronic communication and record-keeping."
  },
  "T24": {
    "name": "T24",
    "type": "text",
    "page": 2,
    "field_label": "lbs",
    "question": "What is the patient's current weight in pounds (lbs)?",
    "context": "Patient's current weight in pounds, used for calculating medication dosage and clinical assessment."
  },
  "T25": {
    "name": "T25",
    "type": "text",
    "page": 2,
    "field_label": "kgs",
    "question": "What is the patient's current weight in kilograms (kgs)?",
    "context": "Patient's current weight in kilograms, alternative unit for medication dosage calculation."
  },
  "T26": {
    "name": "T26",
    "type": "text",
    "page": 2,
    "field_label": "inches",
    "question": "What is the patient's current height in inches?",
    "context": "Patient's current height in inches, used for Body Surface Area (BSA) calculations."
  },
  "T27": {
    "name": "T27",
    "type": "text",
    "page": 2,
    "field_label": "cms",
    "question": "What is the patient's current height in centimeters (cms)?",
    "context": "Patient's current height in centimeters, alternative unit for BSA calculations."
  },
  "T23": {
    "name": "T23",
    "type": "text",
    "page": 2,
    "field_label": "Allergies:",
    "question": "What are the patient's known allergies?",
    "context": "Lists all patient allergies, critical for medication safety and preventing adverse reactions."
  },
  "T28": {
    "name": "T28",
    "type": "text",
    "page": 2,
    "field_label": "Member ID #:",
    "question": "What is the patient's insurance member ID number?",
    "context": "Patient's unique insurance identification number for eligibility and benefits verification."
  },
  "T29": {
    "name": "T29",
    "type": "text",
    "page": 2,
    "field_label": "Group #:",
    "question": "What is the patient's insurance group number?",
    "context": "Patient's insurance group number, identifying their specific plan or employer group."
  },
  "T30": {
    "name": "T30",
    "type": "text",
    "page": 2,
    "field_label": "Insured:",
    "question": "Who is the primary insured party on the patient's policy?",
    "context": "Name of the primary policyholder if different from the patient, for insurance verification."
  },
  "CB31": {
    "name": "CB31",
    "type": "checkbox",
    "page": 2,
    "field_label": "Yes",
    "question": "Does the patient have other insurance coverage?",
    "context": "Indicates if the patient has additional primary or secondary health insurance coverage."
  },
  "CB32": {
    "name": "CB32",
    "type": "checkbox",
    "page": 2,
    "field_label": "No",
    "question": "Does the patient not have other insurance coverage?",
    "context": "Indicates if the patient solely relies on this insurance, without other coverage."
  },
  "T33": {
    "name": "T33",
    "type": "text",
    "page": 2,
    "field_label": "If yes, provide ID#:",
    "question": "If yes, what is the ID number for the patient's other coverage?",
    "context": "Requires the ID number for any additional insurance coverage the patient may have."
  },
  "T34": {
    "name": "T34",
    "type": "text",
    "page": 2,
    "field_label": "Carrier Name:",
    "question": "What is the carrier name of the patient's other insurance?",
    "context": "Name of the insurance company providing the patient's other health coverage."
  },
  "T35": {
    "name": "T35",
    "type": "text",
    "page": 2,
    "field_label": "Insured:",
    "question": "Who is the primary insured party on the patient's other policy?",
    "context": "Name of the primary policyholder for the patient's other insurance coverage."
  },
  "T42": {
    "name": "T42",
    "type": "text",
    "page": 2,
    "field_label": "First Name:",
    "question": "What is the prescriber's first name?",
    "context": "Prescriber's first name for identification and verification in the Prescriber Information section."
  },
  "T43": {
    "name": "T43",
    "type": "text",
    "page": 2,
    "field_label": "Last Name:",
    "question": "What is the prescriber's last name?",
    "context": "Prescriber's last name for identification and verification in the Prescriber Information section."
  },
  "CB44": {
    "name": "CB44",
    "type": "checkbox",
    "page": 2,
    "field_label": "M.D.",
    "question": "Is the prescriber an M.D. (Medical Doctor)?",
    "context": "Prescriber's professional credential (Medical Doctor) for licensing and qualification verification."
  },
  "CB45": {
    "name": "CB45",
    "type": "checkbox",
    "page": 2,
    "field_label": "D.O.",
    "question": "Is the prescriber a D.O. (Doctor of Osteopathic Medicine)?",
    "context": "Prescriber's professional credential (Doctor of Osteopathic Medicine) for licensing verification."
  },
  "CB46": {
    "name": "CB46",
    "type": "checkbox",
    "page": 2,
    "field_label": "N.P.",
    "question": "Is the prescriber an N.P. (Nurse Practitioner)?",
    "context": "Prescriber's professional credential (Nurse Practitioner) for licensing and qualification verification."
  },
  "CB47": {
    "name": "CB47",
    "type": "checkbox",
    "page": 2,
    "field_label": "P.A.",
    "question": "Is the prescriber a P.A. (Physician Assistant)?",
    "context": "Prescriber's professional credential (Physician Assistant) for licensing and qualification verification."
  },
  "T48": {
    "name": "T48",
    "type": "text",
    "page": 2,
    "field_label": "Address:",
    "question": "What is the prescriber's office address?",
    "context": "Prescriber's primary office street address for contact and record-keeping."
  },
  "T49": {
    "name": "T49",
    "type": "text",
    "page": 2,
    "field_label": "City:",
    "question": "What is the city of the prescriber's office?",
    "context": "City of the prescriber's office, part of the complete office address."
  },
  "T50": {
    "name": "T50",
    "type": "text",
    "page": 2,
    "field_label": "State:",
    "question": "What is the state of the prescriber's office?",
    "context": "State of the prescriber's office, part of the complete office address."
  },
  "T51": {
    "name": "T51",
    "type": "text",
    "page": 2,
    "field_label": "ZIP:",
    "question": "What is the ZIP code of the prescriber's office?",
    "context": "ZIP code of the prescriber's office, completing the office address details."
  },
  "T52": {
    "name": "T52",
    "type": "text",
    "page": 2,
    "field_label": "Phone:",
    "question": "What is the prescriber's office phone number?",
    "context": "Prescriber's primary office contact number for direct communication."
  },
  "T53": {
    "name": "T53",
    "type": "text",
    "page": 2,
    "field_label": "Fax:",
    "question": "What is the prescriber's office fax number?",
    "context": "Prescriber's office fax number for sending or receiving medical documentation."
  },
  "T54": {
    "name": "T54",
    "type": "text",
    "page": 2,
    "field_label": "St Lic #:",
    "question": "What is the prescriber's state license number?",
    "context": "Prescriber's state medical license number, essential for verification of credentials."
  },
  "T55": {
    "name": "T55",
    "type": "text",
    "page": 2,
    "field_label": "NPI #:",
    "question": "What is the prescriber's NPI (National Provider Identifier) number?",
    "context": "Prescriber's unique NPI for standardized identification in healthcare transactions."
  },
  "T56": {
    "name": "T56",
    "type": "text",
    "page": 2,
    "field_label": "DEA #:",
    "question": "What is the prescriber's DEA (Drug Enforcement Administration) number?",
    "context": "Prescriber's DEA registration number, required for prescribing controlled substances."
  },
  "T57": {
    "name": "T57",
    "type": "text",
    "page": 2,
    "field_label": "UPIN:",
    "question": "What is the prescriber's UPIN (Unique Physician Identification Number)?",
    "context": "Prescriber's UPIN, if applicable, for physician identification (legacy identifier)."
  },
  "T58.0": {
    "name": "T58.0",
    "type": "text",
    "page": 2,
    "field_label": "Provider Email:",
    "question": "What is the prescriber's email address?",
    "context": "Prescriber's email address for electronic communication regarding patient care."
  },
  "T58.1": {
    "name": "T58.1",
    "type": "text",
    "page": 2,
    "field_label": "Office Contact Name:",
    "question": "What is the name of the primary contact person at the prescriber's office?",
    "context": "Name of a key administrative contact at the prescriber's office for PA inquiries."
  },
  "T59": {
    "name": "T59",
    "type": "text",
    "page": 2,
    "field_label": "Phone:",
    "question": "What is the phone number for the prescriber's office contact?",
    "context": "Direct phone number for the specified office contact person, if different from main office."
  },
  "Provider Admin CB.1": {
    "name": "Provider Admin CB.1",
    "type": "checkbox",
    "page": 2,
    "field_label": "Self-administered",
    "question": "Is the medication self-administered by the patient?",
    "context": "Indicates if the patient takes the medication independently, affecting dispensing location."
  },
  "Provider Admin CB.2": {
    "name": "Provider Admin CB.2",
    "type": "checkbox",
    "page": 2,
    "field_label": "Physician’s Office",
    "question": "Will the medication be administered in the physician's office?",
    "context": "Indicates the medication will be administered at the prescriber's office, common for infused drugs."
  },
  "Provider Admin CB.3": {
    "name": "Provider Admin CB.3",
    "type": "checkbox",
    "page": 2,
    "field_label": "Home",
    "question": "Will the medication be administered at the patient's home?",
    "context": "Indicates if the patient will receive the medication at home, common for home health services."
  },
  "Provider Admin CB.4": {
    "name": "Provider Admin CB.4",
    "type": "checkbox",
    "page": 2,
    "field_label": "Outpatient Infusion Center",
    "question": "Will the medication be administered at an outpatient infusion center?",
    "context": "Indicates administration at a dedicated outpatient infusion facility."
  },
  "Provider Admin T.5": {
    "name": "Provider Admin T.5",
    "type": "text",
    "page": 2,
    "field_label": "Name:",
    "question": "What is the name of the outpatient infusion center?",
    "context": "Name of the specific outpatient infusion center where medication will be administered."
  },
  "Provider Admin CB.7": {
    "name": "Provider Admin CB.7",
    "type": "checkbox",
    "page": 2,
    "field_label": "Home Infusion Center",
    "question": "Will the medication be administered by a home infusion center?",
    "context": "Indicates if a specialized home infusion service will administer the medication at home."
  },
  "Provider Admin T.6": {
    "name": "Provider Admin T.6",
    "type": "text",
    "page": 2,
    "field_label": "Phone:",
    "question": "What is the phone number of the home infusion center?",
    "context": "Phone number of the home infusion center for scheduling and coordination."
  },
  "Provider Admin T.8": {
    "name": "Provider Admin T.8",
    "type": "text",
    "page": 2,
    "field_label": "Agency Name:",
    "question": "What is the name of the home infusion agency?",
    "context": "Name of the home infusion agency providing services, if applicable."
  },
  "Provider Admin CB.10": {
    "name": "Provider Admin CB.10",
    "type": "checkbox",
    "page": 2,
    "field_label": "Administration code(s)",
    "question": "Are administration code(s) being provided for this request?",
    "context": "Checkbox to indicate if relevant CPT administration codes will be included for the service."
  },
  "Provider Admin T.9": {
    "name": "Provider Admin T.9",
    "type": "text",
    "page": 2,
    "field_label": "CPT:",
    "question": "What are the CPT administration code(s) for this service?",
    "context": "Specific CPT codes for the medication's administration, vital for billing and service description."
  },
  "Provider Admin T.11A": {
    "name": "Provider Admin T.11A",
    "type": "text",
    "page": 2,
    "field_label": "Address:",
    "question": "What is the address for the dispensing provider/administration location?",
    "context": "Street address of the dispensing provider or administration facility."
  },
  "Provider Admin T.13": {
    "name": "Provider Admin T.13",
    "type": "text",
    "page": 2,
    "field_label": "City:",
    "question": "What is the city for the dispensing provider/administration location?",
    "context": "City of the dispensing provider or administration facility."
  },
  "Provider Admin T.14": {
    "name": "Provider Admin T.14",
    "type": "text",
    "page": 2,
    "field_label": "State:",
    "question": "What is the state for the dispensing provider/administration location?",
    "context": "State of the dispensing provider or administration facility."
  },
  "Provider Admin T.15": {
    "name": "Provider Admin T.15",
    "type": "text",
    "page": 2,
    "field_label": "ZIP:",
    "question": "What is the ZIP code for the dispensing provider/administration location?",
    "context": "ZIP code of the dispensing provider or administration facility."
  },
  "Provider Admin T.16": {
    "name": "Provider Admin T.16",
    "type": "text",
    "page": 2,
    "field_label": "Phone:",
    "question": "What is the phone number for the dispensing provider/administration location?",
    "context": "Contact phone number for the dispensing provider or administration facility."
  },
  "Provider Admin T.17A": {
    "name": "Provider Admin T.17A",
    "type": "text",
    "page": 2,
    "field_label": "Fax:",
    "question": "What is the fax number for the dispensing provider/administration location?",
    "context": "Fax number for the dispensing provider or administration facility for document transmission."
  },
  "Provider Admin T.18": {
    "name": "Provider Admin T.18",
    "type": "text",
    "page": 2,
    "field_label": "TIN:",
    "question": "What is the Tax Identification Number (TIN) for the dispensing provider/administration location?",
    "context": "TIN of the dispensing provider or administration facility, used for tax and billing purposes."
  },
  "Provider Admin T.19": {
    "name": "Provider Admin T.19",
    "type": "text",
    "page": 2,
    "field_label": "PIN:",
    "question": "What is the Provider Identification Number (PIN) for the dispensing provider/administration location?",
    "context": "PIN of the dispensing provider or administration facility for unique identification."
  },
  "Provider Admin T.20": {
    "name": "Provider Admin T.20",
    "type": "text",
    "page": 2,
    "field_label": "NPI:",
    "question": "What is the NPI (National Provider Identifier) for the dispensing provider/administration location?",
    "context": "NPI of the dispensing provider or administration facility for standardized identification."
  },
  "Provider Admin CB.21": {
    "name": "Provider Admin CB.21",
    "type": "checkbox",
    "page": 2,
    "field_label": "Outpatient Dialysis Center",
    "question": "Will the medication be dispensed/administered at an outpatient dialysis center?",
    "context": "Checkbox indicating if the medication will be provided by an outpatient dialysis center."
  },
  "Provider Admin CB.22": {
    "name": "Provider Admin CB.22",
    "type": "checkbox",
    "page": 2,
    "field_label": "Physician’s Office",
    "question": "Will the medication be dispensed/administered at a physician's office?",
    "context": "Checkbox indicating if the medication will be provided by a physician's office."
  },
  "Provider Admin CB.23.0.0": {
    "name": "Provider Admin CB.23.0.0",
    "type": "checkbox",
    "page": 2,
    "field_label": "Retail Pharmacy",
    "question": "Will the medication be dispensed by a retail pharmacy?",
    "context": "Checkbox indicating if the medication will be obtained from a retail pharmacy."
  },
  "Provider Admin CB.24.0.0": {
    "name": "Provider Admin CB.24.0.0",
    "type": "checkbox",
    "page": 2,
    "field_label": "Specialty Pharmacy",
    "question": "Will the medication be dispensed by a specialty pharmacy?",
    "context": "Checkbox indicating if the medication will be obtained from a specialty pharmacy."
  },
  "Provider Admin CB.25": {
    "name": "Provider Admin CB.25",
    "type": "checkbox",
    "page": 2,
    "field_label": "Mail Order",
    "question": "Will the medication be dispensed by mail order?",
    "context": "Checkbox indicating if the medication will be delivered via mail order pharmacy services."
  },
  "Provider Admin CB.26": {
    "name": "Provider Admin CB.26",
    "type": "checkbox",
    "page": 2,
    "field_label": "Other:",
    "question": "Will the medication be dispensed/administered by another type of facility not listed?",
    "context": "Option to specify an alternative dispensing or administration location not pre-listed."
  },
  "Provider Admin T.27": {
    "name": "Provider Admin T.27",
    "type": "text",
    "page": 2,
    "field_label": "Other:",
    "question": "Please specify the 'Other' dispensing/administration location.",
    "context": "Text field to describe the specific 'other' dispensing/administration location if the checkbox is selected."
  },
  "Provider Admin T.28": {
    "name": "Provider Admin T.28",
    "type": "text",
    "page": 2,
    "field_label": "Name:",
    "question": "What is the name of the dispensing provider/pharmacy?",
    "context": "Name of the entity responsible for dispensing the medication."
  },
  "Provider Admin T.29a": {
    "name": "Provider Admin T.29a",
    "type": "text",
    "page": 2,
    "field_label": "Address:",
    "question": "What is the address of the dispensing provider/pharmacy?",
    "context": "Street address of the dispensing provider or pharmacy."
  },
  "Provider Admin T.30a": {
    "name": "Provider Admin T.30a",
    "type": "text",
    "page": 2,
    "field_label": "City:",
    "question": "What is the city of the dispensing provider/pharmacy?",
    "context": "City of the dispensing provider or pharmacy."
  },
  "Provider Admin T.31": {
    "name": "Provider Admin T.31",
    "type": "text",
    "page": 2,
    "field_label": "State:",
    "question": "What is the state of the dispensing provider/pharmacy?",
    "context": "State of the dispensing provider or pharmacy."
  },
  "Provider Admin T.32": {
    "name": "Provider Admin T.32",
    "type": "text",
    "page": 2,
    "field_label": "ZIP:",
    "question": "What is the ZIP code of the dispensing provider/pharmacy?",
    "context": "ZIP code of the dispensing provider or pharmacy."
  },
  "Provider Admin T.33": {
    "name": "Provider Admin T.33",
    "type": "text",
    "page": 2,
    "field_label": "Phone:",
    "question": "What is the phone number for the dispensing provider/pharmacy?",
    "context": "Contact phone number for the dispensing provider or pharmacy."
  },
  "Provider Admin T.34": {
    "name": "Provider Admin T.34",
    "type": "text",
    "page": 2,
    "field_label": "Fax:",
    "question": "What is the fax number for the dispensing provider/pharmacy?",
    "context": "Fax number for the dispensing provider or pharmacy for document transmission."
  },
  "Provider Admin T.35": {
    "name": "Provider Admin T.35",
    "type": "text",
    "page": 2,
    "field_label": "TIN:",
    "question": "What is the Tax Identification Number (TIN) for the dispensing provider/pharmacy?",
    "context": "TIN of the dispensing provider or pharmacy for tax and billing purposes."
  },
  "Provider Admin T.36": {
    "name": "Provider Admin T.36",
    "type": "text",
    "page": 2,
    "field_label": "PIN:",
    "question": "What is the Provider Identification Number (PIN) for the dispensing provider/pharmacy?",
    "context": "PIN of the dispensing provider or pharmacy for unique identification."
  },
  "Provider Admin T.37": {
    "name": "Provider Admin T.37",
    "type": "text",
    "page": 2,
    "field_label": "NPI:",
    "question": "What is the NPI (National Provider Identifier) for the dispensing provider/pharmacy?",
    "context": "NPI of the dispensing provider or pharmacy for standardized identification."
  },
  "CB60": {
    "name": "CB60",
    "type": "checkbox",
    "page": 2,
    "field_label": "Riabni (rituximab-arrx)",
    "question": "Is the requested product Riabni (rituximab-arrx)?",
    "context": "Selection for Riabni, a non-preferred rituximab biosimilar, in the Product Information section."
  },
  "CB61": {
    "name": "CB61",
    "type": "checkbox",
    "page": 2,
    "field_label": "Rituxan (rituximab)",
    "question": "Is the requested product Rituxan (rituximab)?",
    "context": "Selection for Rituxan, a non-preferred rituximab product, in the Product Information section."
  },
  "CB62": {
    "name": "CB62",
    "type": "checkbox",
    "page": 2,
    "field_label": "Ruxience (rituximab-pvvr)",
    "question": "Is the requested product Ruxience (rituximab-pvvr)?",
    "context": "Selection for Ruxience, a preferred rituximab biosimilar, in the Product Information section."
  },
  "CB63": {
    "name": "CB63",
    "type": "checkbox",
    "page": 2,
    "field_label": "Truxima (rituximab-abbs)",
    "question": "Is the requested product Truxima (rituximab-abbs)?",
    "context": "Selection for Truxima, a preferred rituximab biosimilar, in the Product Information section."
  },
  "T64": {
    "name": "T64",
    "type": "text",
    "page": 2,
    "field_label": "Dose:",
    "question": "What is the prescribed dose of the requested medication?",
    "context": "Prescribed dosage of the medication, essential for clinical review and safety."
  },
  "T65": {
    "name": "T65",
    "type": "text",
    "page": 2,
    "field_label": "Directions for Use:",
    "question": "What are the directions for use of the requested medication?",
    "context": "Instructions for medication administration, including frequency and route, for clinical assessment."
  },
  "T66": {
    "name": "T66",
    "type": "text",
    "page": 2,
    "field_label": "HCPCS Code:",
    "question": "What is the HCPCS code for the requested medication or service?",
    "context": "HCPCS code identifying the specific drug or service for billing and coverage determination."
  },
  "T67": {
    "name": "T67",
    "type": "text",
    "page": 2,
    "field_label": "Primary ICD Code:",
    "question": "What is the primary ICD code for the patient's diagnosis?",
    "context": "Primary International Classification of Diseases (ICD) code describing the patient's main diagnosis."
  },
  "CB68": {
    "name": "CB68",
    "type": "checkbox",
    "page": 2,
    "field_label": "Other ICD Code:",
    "question": "Are there other ICD codes applicable to the patient's diagnosis?",
    "context": "Checkbox indicating if additional ICD codes will be provided for other relevant diagnoses."
  },
  "T69": {
    "name": "T69",
    "type": "text",
    "page": 2,
    "field_label": "Other ICD Code:",
    "question": "What are the other applicable ICD codes?",
    "context": "Lists additional ICD codes for co-morbidities or secondary diagnoses, if applicable."
  },
  "CB70": {
    "name": "CB70",
    "type": "checkbox",
    "page": 2,
    "field_label": "Yes",
    "question": "Has the patient received prior therapy with the requested product within the last 365 days?",
    "context": "Indicates if the patient has recent experience with the specific medication being requested."
  },
  "CB71": {
    "name": "CB71",
    "type": "checkbox",
    "page": 2,
    "field_label": "No",
    "question": "Has the patient not received prior therapy with the requested product within the last 365 days?",
    "context": "Indicates if the patient has no recent history of therapy with the requested medication."
  },
  "CB72": {
    "name": "CB72",
    "type": "checkbox",
    "page": 2,
    "field_label": "No",
    "question": "Has the patient NOT had a trial and failure of any rituximab biosimilars listed?",
    "context": "Indicates if the patient has not failed preferred rituximab biosimilars, influencing product selection."
  },
  "CB73": {
    "name": "CB73",
    "type": "checkbox",
    "page": 2,
    "field_label": "Ruxience (rituximab-pvvr)",
    "question": "Has the patient had a trial and failure of Ruxience (rituximab-pvvr)?",
    "context": "Indicates if the patient has failed a trial of the preferred rituximab biosimilar Ruxience."
  },
  "CB74": {
    "name": "CB74",
    "type": "checkbox",
    "page": 2,
    "field_label": "Truxima (rituximab-abbs)",
    "question": "Has the patient had a trial and failure of Truxima (rituximab-abbs)?",
    "context": "Indicates if the patient has failed a trial of the preferred rituximab biosimilar Truxima."
  },
  "T75": {
    "name": "T75",
    "type": "text",
    "page": 2,
    "field_label": "When was the member’s trial and failure of the preferred drug?",
    "question": "When did the patient's trial and failure of the preferred drug occur?",
    "context": "Date of documented trial failure of preferred biosimilars, supporting the current request."
  },
  "T76": {
    "name": "T76",
    "type": "text",
    "page": 2,
    "field_label": "Please describe the nature of the failure of the preferred drug",
    "question": "What was the nature of the patient's failure with the preferred drug?",
    "context": "Detailed explanation of why the preferred medication failed, for medical necessity review."
  },
  "CB77": {
    "name": "CB77",
    "type": "checkbox",
    "page": 2,
    "field_label": "No",
    "question": "Has the patient NOT had an adverse reaction to any rituximab biosimilars listed?",
    "context": "Indicates if the patient has not experienced adverse reactions to preferred rituximab biosimilars."
  },
  "CB78": {
    "name": "CB78",
    "type": "checkbox",
    "page": 2,
    "field_label": "Ruxience (rituximab-pvvr)",
    "question": "Has the patient had an adverse reaction to Ruxience (rituximab-pvvr)?",
    "context": "Indicates if the patient experienced an adverse reaction to the preferred biosimilar Ruxience."
  },
  "CB79": {
    "name": "CB79",
    "type": "checkbox",
    "page": 2,
    "field_label": "Truxima (rituximab-abbs)",
    "question": "Has the patient had an adverse reaction to Truxima (rituximab-abbs)?",
    "context": "Indicates if the patient experienced an adverse reaction to the preferred biosimilar Truxima."
  },
  "T80": {
    "name": "T80",
    "type": "text",
    "page": 2,
    "field_label": "When was the member’s adverse reaction to the preferred drug?",
    "question": "When did the patient's adverse reaction to the preferred drug occur?",
    "context": "Date of documented adverse reaction to preferred biosimilars, supporting current request."
  },
  "T81": {
    "name": "T81",
    "type": "text",
    "page": 2,
    "field_label": "Please describe the nature of the adverse reaction to the preferred drug",
    "question": "What was the nature of the patient's adverse reaction to the preferred drug?",
    "context": "Detailed explanation of the adverse reaction to the preferred medication, for medical necessity."
  },
  "T84": {
    "name": "T84",
    "type": "text",
    "page": 2,
    "field_label": "Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred biosimilar products when indicated for the patient’s diagnosis?",
    "question": "Please explain any contraindications or medical reasons preventing the patient from using preferred rituximab biosimilars.",
    "context": "Requires a clinical justification for not using preferred biosimilar rituximab options, if applicable."
  },
  "CB82": {
    "name": "CB82",
    "type": "checkbox",
    "page": 2,
    "field_label": "Ruxience (rituximab-pvvr)",
    "question": "Is Ruxience (rituximab-pvvr) contraindicated or medically unsuitable for the patient's diagnosis?",
    "context": "Indicates a contraindication or medical reason preventing the use of Ruxience for the patient."
  },
  "CB83": {
    "name": "CB83",
    "type": "checkbox",
    "page": 2,
    "field_label": "Truxima (rituximab-abbs)",
    "question": "Is Truxima (rituximab-abbs) contraindicated or medically unsuitable for the patient's diagnosis?",
    "context": "Indicates a contraindication or medical reason preventing the use of Truxima for the patient."
  },
  "CB86": {
    "name": "CB86",
    "type": "checkbox",
    "page": 3,
    "field_label": "Inflectra (infliximab-dyyb)",
    "question": "Has the patient had a trial and failure of Inflectra (infliximab-dyyb)?",
    "context": "Indicates if Inflectra, a preferred biosimilar, was tried and failed as prior therapy."
  },
  "CB87": {
    "name": "CB87",
    "type": "checkbox",
    "page": 3,
    "field_label": "Renflexis (infliximab-abda)",
    "question": "Has the patient had a trial and failure of Renflexis (infliximab-abda)?",
    "context": "Indicates if Renflexis, a preferred biosimilar, was tried and failed as prior therapy."
  },
  "CB88": {
    "name": "CB88",
    "type": "checkbox",
    "page": 3,
    "field_label": "Simponi Aria (golimumab)",
    "question": "Has the patient had a trial and failure of Simponi Aria (golimumab)?",
    "context": "Indicates if Simponi Aria, a preferred biologic, was tried and failed as prior therapy."
  },
  "T89": {
    "name": "T89",
    "type": "text",
    "page": 3,
    "field_label": "When was the member’s trial and failure of the preferred drug?",
    "question": "When did the patient experience trial and failure of the preferred drug?",
    "context": "Date of trial and failure for the previously selected preferred biosimilar or biologic."
  },
  "T90": {
    "name": "T90",
    "type": "text",
    "page": 3,
    "field_label": "Please describe the nature of the failure of the preferred drug",
    "question": "Please describe how the preferred drug trial failed.",
    "context": "Detailed explanation of clinical reasons for failure of prior preferred therapy."
  },
  "CB85": {
    "name": "CB85",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Has the patient NOT had a trial and failure of Inflectra, Renflexis, or Simponi Aria?",
    "context": "Indicates no prior trial and failure of listed preferred therapies for patient. Dependent on parent question."
  },
  "CB92": {
    "name": "CB92",
    "type": "checkbox",
    "page": 3,
    "field_label": "Inflectra (infliximab-dyyb)",
    "question": "Has the patient had an adverse reaction to Inflectra (infliximab-dyyb)?",
    "context": "Indicates if Inflectra, a preferred biosimilar, caused an adverse reaction for patient."
  },
  "CB93": {
    "name": "CB93",
    "type": "checkbox",
    "page": 3,
    "field_label": "Renflexis (infliximab-abda)",
    "question": "Has the patient had an adverse reaction to Renflexis (infliximab-abda)?",
    "context": "Indicates if Renflexis, a preferred biosimilar, caused an adverse reaction for patient."
  },
  "CB94": {
    "name": "CB94",
    "type": "checkbox",
    "page": 3,
    "field_label": "Simponi Aria (golimumab)",
    "question": "Has the patient had an adverse reaction to Simponi Aria (golimumab)?",
    "context": "Indicates if Simponi Aria, a preferred biologic, caused an adverse reaction for patient."
  },
  "T95": {
    "name": "T95",
    "type": "text",
    "page": 3,
    "field_label": "When was the member’s adverse reaction to the preferred drug?",
    "question": "When did the patient experience an adverse reaction to the preferred drug?",
    "context": "Date of adverse reaction to the previously selected preferred biosimilar or biologic."
  },
  "T96a": {
    "name": "T96a",
    "type": "text",
    "page": 3,
    "field_label": "Please describe the nature of the adverse reaction to the preferred drug",
    "question": "Please describe the adverse reaction to the preferred drug.",
    "context": "Detailed explanation of the adverse event encountered with prior preferred therapy."
  },
  "CB91": {
    "name": "CB91",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Has the patient NOT had an adverse reaction to Inflectra, Renflexis, or Simponi Aria?",
    "context": "Indicates no prior adverse reaction to listed preferred therapies for patient. Dependent on parent question."
  },
  "CB98a": {
    "name": "CB98a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Enbrel (etanercept)",
    "question": "Has the patient had a trial and failure of Enbrel (etanercept)?",
    "context": "Indicates if Enbrel, a preferred MA plan therapy, was tried and failed as prior therapy."
  },
  "CB99a": {
    "name": "CB99a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Humira (adalimumab)",
    "question": "Has the patient had a trial and failure of Humira (adalimumab)?",
    "context": "Indicates if Humira, a preferred MA plan therapy, was tried and failed as prior therapy."
  },
  "CB100a": {
    "name": "CB100a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Idacio (adalimumab-aacf)",
    "question": "Has the patient had a trial and failure of Idacio (adalimumab-aacf)?",
    "context": "Indicates if Idacio, a preferred MA plan therapy, was tried and failed as prior therapy."
  },
  "CB101a": {
    "name": "CB101a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Rinvoq (upadacitinib)",
    "question": "Has the patient had a trial and failure of Rinvoq (upadacitinib)?",
    "context": "Indicates if Rinvoq, a preferred MA plan therapy, was tried and failed as prior therapy."
  },
  "CB102a": {
    "name": "CB102a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Tyenne SC (tocilizumab-aazg)",
    "question": "Has the patient had a trial and failure of Tyenne SC (tocilizumab-aazg)?",
    "context": "Indicates if Tyenne SC, a preferred MA plan therapy, was tried and failed as prior therapy."
  },
  "CB103a": {
    "name": "CB103a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Xeljanz/Xeljanz XR (tofacitinib)",
    "question": "Has the patient had a trial and failure of Xeljanz/Xeljanz XR (tofacitinib)?",
    "context": "Indicates if Xeljanz/Xeljanz XR, a preferred MA plan therapy, was tried and failed as prior therapy."
  },
  "T104": {
    "name": "T104",
    "type": "text",
    "page": 3,
    "field_label": "When was the member’s trial and failure of the preferred drug?",
    "question": "When did the patient experience trial and failure of the preferred drug?",
    "context": "Date of trial and failure for the previously selected preferred MA plan drug."
  },
  "T105": {
    "name": "T105",
    "type": "text",
    "page": 3,
    "field_label": "Please describe the nature of the failure of the preferred drug",
    "question": "Please describe how the preferred drug trial failed.",
    "context": "Detailed explanation of clinical reasons for failure of prior preferred MA plan therapy."
  },
  "CB97": {
    "name": "CB97",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Has the patient NOT had a trial and failure of any listed preferred MA plan drug?",
    "context": "Indicates no prior trial and failure of listed preferred MA plan therapies for patient. Dependent on parent question."
  },
  "CB107z": {
    "name": "CB107z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Enbrel (etanercept)",
    "question": "Has the patient had an adverse reaction to Enbrel (etanercept)?",
    "context": "Indicates if Enbrel, a preferred MA plan therapy, caused an adverse reaction for patient."
  },
  "CB108z": {
    "name": "CB108z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Humira (adalimumab)",
    "question": "Has the patient had an adverse reaction to Humira (adalimumab)?",
    "context": "Indicates if Humira, a preferred MA plan therapy, caused an adverse reaction for patient."
  },
  "CB109z": {
    "name": "CB109z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Idacio (adalimumab-aacf)",
    "question": "Has the patient had an adverse reaction to Idacio (adalimumab-aacf)?",
    "context": "Indicates if Idacio, a preferred MA plan therapy, caused an adverse reaction for patient."
  },
  "CB110z": {
    "name": "CB110z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Rinvoq (upadacitinib)",
    "question": "Has the patient had an adverse reaction to Rinvoq (upadacitinib)?",
    "context": "Indicates if Rinvoq, a preferred MA plan therapy, caused an adverse reaction for patient."
  },
  "CB111z": {
    "name": "CB111z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Tyenne SC (tocilizumab-aazg)",
    "question": "Has the patient had an adverse reaction to Tyenne SC (tocilizumab-aazg)?",
    "context": "Indicates if Tyenne SC, a preferred MA plan therapy, caused an adverse reaction for patient."
  },
  "CB112z": {
    "name": "CB112z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Xeljanz/Xeljanz XR (tofacitinib)",
    "question": "Has the patient had an adverse reaction to Xeljanz/Xeljanz XR (tofacitinib)?",
    "context": "Indicates if Xeljanz/Xeljanz XR, a preferred MA plan therapy, caused an adverse reaction for patient."
  },
  "T113": {
    "name": "T113",
    "type": "text",
    "page": 3,
    "field_label": "When was the member’s adverse reaction to the preferred drug?",
    "question": "When did the patient experience an adverse reaction to the preferred drug?",
    "context": "Date of adverse reaction to the previously selected preferred MA plan drug."
  },
  "T114": {
    "name": "T114",
    "type": "text",
    "page": 3,
    "field_label": "Please describe the nature of the adverse reaction to the preferred drug",
    "question": "Please describe the adverse reaction to the preferred drug.",
    "context": "Detailed explanation of the adverse event encountered with prior preferred MA plan therapy."
  },
  "CB106z": {
    "name": "CB106z",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Has the patient NOT had an adverse reaction to any listed preferred MA plan drug?",
    "context": "Indicates no prior adverse reaction to listed preferred MA plan therapies for patient. Dependent on parent question."
  },
  "T118": {
    "name": "T118",
    "type": "text",
    "page": 3,
    "field_label": "Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred products when indicated for the patient’s diagnosis?",
    "question": "Please explain contraindications or other medical reasons preventing the patient from using the preferred biosimilars (Inflectra, Renflexis, Simponi Aria) for the diagnosis.",
    "context": "Explanation for not using preferred infliximab biosimilars/biologic due to contraindications or other medical reasons."
  },
  "CB115z": {
    "name": "CB115z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Inflectra (infliximab-dyyb)",
    "question": "Is Inflectra (infliximab-dyyb) contraindicated for this patient's diagnosis?",
    "context": "Indicates if Inflectra is contraindicated for the patient's specific diagnosis."
  },
  "CB116z": {
    "name": "CB116z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Renflexis (infliximab-abda)",
    "question": "Is Renflexis (infliximab-abda) contraindicated for this patient's diagnosis?",
    "context": "Indicates if Renflexis is contraindicated for the patient's specific diagnosis."
  },
  "CB117z": {
    "name": "CB117z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Simponi Aria (golimumab)",
    "question": "Is Simponi Aria (golimumab) contraindicated for this patient's diagnosis?",
    "context": "Indicates if Simponi Aria is contraindicated for the patient's specific diagnosis."
  },
  "T125": {
    "name": "T125",
    "type": "text",
    "page": 3,
    "field_label": "Please explain if there are contraindications or any other medical reason(s) that the patient cannot use any of the following preferred products when indicated for the patient’s diagnosis?",
    "question": "Please explain contraindications or other medical reasons preventing the patient from using the preferred MA plan drugs (Enbrel, Humira, Idacio, Rinvoq, Tyenne SC, Xeljanz/Xeljanz XR) for the diagnosis.",
    "context": "Explanation for not using preferred MA plan drugs due to contraindications or other medical reasons for patient's diagnosis."
  },
  "CB119z": {
    "name": "CB119z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Enbrel (etanercept)",
    "question": "Is Enbrel (etanercept) contraindicated for this patient's diagnosis?",
    "context": "Indicates if Enbrel is contraindicated for the patient's specific diagnosis."
  },
  "CB120z": {
    "name": "CB120z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Humira (adalimumab)",
    "question": "Is Humira (adalimumab) contraindicated for this patient's diagnosis?",
    "context": "Indicates if Humira is contraindicated for the patient's specific diagnosis."
  },
  "CB121z": {
    "name": "CB121z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Idacio (adalimumab-aacf)",
    "question": "Is Idacio (adalimumab-aacf) contraindicated for this patient's diagnosis?",
    "context": "Indicates if Idacio is contraindicated for the patient's specific diagnosis."
  },
  "CB122z": {
    "name": "CB122z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Rinvoq (upadacitinib)",
    "question": "Is Rinvoq (upadacitinib) contraindicated for this patient's diagnosis?",
    "context": "Indicates if Rinvoq is contraindicated for the patient's specific diagnosis."
  },
  "CB123z": {
    "name": "CB123z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Tyenne SC (tocilizumab-aazg)",
    "question": "Is Tyenne SC (tocilizumab-aazg) contraindicated for this patient's diagnosis?",
    "context": "Indicates if Tyenne SC is contraindicated for the patient's specific diagnosis."
  },
  "CB124z": {
    "name": "CB124z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Xeljanz/Xeljanz XR (tofacitinib)",
    "question": "Is Xeljanz/Xeljanz XR (tofacitinib) contraindicated for this patient's diagnosis?",
    "context": "Indicates if Xeljanz/Xeljanz XR is contraindicated for the patient's specific diagnosis."
  },
  "CB96.4.0": {
    "name": "CB96.4.0",
    "type": "checkbox",
    "page": 3,
    "field_label": "Yes",
    "question": "Will Rituxan be used concomitantly with apremilast, tofacitinib, or other biologic DMARDs?",
    "context": "Indicates if Rituxan will be co-administered with other DMARDs, relevant for drug interaction assessment."
  },
  "CB98": {
    "name": "CB98",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Will Rituxan NOT be used concomitantly with apremilast, tofacitinib, or other biologic DMARDs?",
    "context": "Indicates no co-administration of Rituxan with other DMARDs, relevant for drug interaction assessment."
  },
  "CB99.0": {
    "name": "CB99.0",
    "type": "checkbox",
    "page": 3,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)?",
    "context": "Confirms patient's diagnosis of specific acute lymphoid leukemia subtype."
  },
  "CB100.0": {
    "name": "CB100.0",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Does the patient NOT have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)?",
    "context": "Denies specific acute lymphoid leukemia diagnosis for the patient."
  },
  "CB101.0": {
    "name": "CB101.0",
    "type": "checkbox",
    "page": 3,
    "field_label": "Yes",
    "question": "Is Rituxan (rituximab) being used as induction/consolidation therapy for ALL?",
    "context": "Confirms Rituxan's role as induction/consolidation therapy for acute lymphoid leukemia."
  },
  "CB102.0": {
    "name": "CB102.0",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Is Rituxan (rituximab) NOT being used as induction/consolidation therapy for ALL?",
    "context": "Denies Rituxan's role as induction/consolidation therapy for acute lymphoid leukemia."
  },
  "CB103": {
    "name": "CB103",
    "type": "checkbox",
    "page": 3,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of refractory autoimmune hemolytic anemia?",
    "context": "Confirms patient's diagnosis of autoimmune hemolytic anemia refractory to other treatments."
  },
  "CB104": {
    "name": "CB104",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Does the patient NOT have a documented diagnosis of refractory autoimmune hemolytic anemia?",
    "context": "Denies refractory autoimmune hemolytic anemia diagnosis for the patient."
  },
  "CB104a": {
    "name": "CB104a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Wegener granulomatosis",
    "question": "Does the patient have Wegener granulomatosis?",
    "context": "Identifies Wegener granulomatosis as the specific ANCA-associated vasculitis diagnosis."
  },
  "CB104b": {
    "name": "CB104b",
    "type": "checkbox",
    "page": 3,
    "field_label": "Churg-Strauss syndrome",
    "question": "Does the patient have Churg-Strauss syndrome?",
    "context": "Identifies Churg-Strauss syndrome as the specific ANCA-associated vasculitis diagnosis."
  },
  "CB104c": {
    "name": "CB104c",
    "type": "checkbox",
    "page": 3,
    "field_label": "microscopic polyangiitis",
    "question": "Does the patient have microscopic polyangiitis?",
    "context": "Identifies microscopic polyangiitis as the specific ANCA-associated vasculitis diagnosis."
  },
  "CB104d": {
    "name": "CB104d",
    "type": "checkbox",
    "page": 3,
    "field_label": "pauci-immune glomerulonephritis",
    "question": "Does the patient have pauci-immune glomerulonephritis?",
    "context": "Identifies pauci-immune glomerulonephritis as the specific ANCA-associated vasculitis diagnosis."
  },
  "CB105": {
    "name": "CB105",
    "type": "checkbox",
    "page": 3,
    "field_label": "Yes",
    "question": "Will Rituxan (rituximab) be given in conjunction with glucocorticoids?",
    "context": "Indicates if Rituxan will be co-administered with glucocorticoids for ANCA-associated vasculitides treatment."
  },
  "CB106": {
    "name": "CB106",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Will Rituxan (rituximab) NOT be given in conjunction with glucocorticoids?",
    "context": "Indicates no co-administration of Rituxan with glucocorticoids for ANCA-associated vasculitides treatment."
  },
  "CB106a": {
    "name": "CB106a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of corticosteroid-refractory autoimmune blistering disease?",
    "context": "Confirms patient's diagnosis of autoimmune blistering disease refractory to corticosteroids."
  },
  "CB107": {
    "name": "CB107",
    "type": "checkbox",
    "page": 3,
    "field_label": "pemphigus vulgaris",
    "question": "Does the patient have pemphigus vulgaris?",
    "context": "Identifies pemphigus vulgaris as the specific autoimmune blistering disease diagnosis."
  },
  "CB108": {
    "name": "CB108",
    "type": "checkbox",
    "page": 3,
    "field_label": "pemphigus folliaceus",
    "question": "Does the patient have pemphigus folliaceus?",
    "context": "Identifies pemphigus folliaceus as the specific autoimmune blistering disease diagnosis."
  },
  "CB109": {
    "name": "CB109",
    "type": "checkbox",
    "page": 3,
    "field_label": "bullous pemphigoid",
    "question": "Does the patient have bullous pemphigoid?",
    "context": "Identifies bullous pemphigoid as the specific autoimmune blistering disease diagnosis."
  },
  "CB110": {
    "name": "CB110",
    "type": "checkbox",
    "page": 3,
    "field_label": "cicatricial pemphigoid",
    "question": "Does the patient have cicatricial pemphigoid?",
    "context": "Identifies cicatricial pemphigoid as the specific autoimmune blistering disease diagnosis."
  },
  "CB111": {
    "name": "CB111",
    "type": "checkbox",
    "page": 3,
    "field_label": "epidermolysis bullosa acquisita",
    "question": "Does the patient have epidermolysis bullosa acquisita?",
    "context": "Identifies epidermolysis bullosa acquisita as the specific autoimmune blistering disease diagnosis."
  },
  "CB112": {
    "name": "CB112",
    "type": "checkbox",
    "page": 3,
    "field_label": "paraneoplastic pemphigus",
    "question": "Does the patient have paraneoplastic pemphigus?",
    "context": "Identifies paraneoplastic pemphigus as the specific autoimmune blistering disease diagnosis."
  },
  "CB113": {
    "name": "CB113",
    "type": "checkbox",
    "page": 3,
    "field_label": "None of the above",
    "question": "Is the patient's autoimmune blistering disease NOT among the listed options?",
    "context": "Indicates if the patient's specific autoimmune blistering disease diagnosis is not provided in the list."
  },
  "CB106b": {
    "name": "CB106b",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Does the patient NOT have a documented diagnosis of corticosteroid-refractory autoimmune blistering disease?",
    "context": "Denies corticosteroid-refractory autoimmune blistering disease diagnosis for the patient."
  },
  "CB114": {
    "name": "CB114",
    "type": "checkbox",
    "page": 3,
    "field_label": "AIDS-related B-cell lymphoma",
    "question": "Does the patient have AIDS-related B-cell lymphoma?",
    "context": "Identifies AIDS-related B-cell lymphoma as the specific B-cell lymphoma diagnosis."
  },
  "CB115": {
    "name": "CB115",
    "type": "checkbox",
    "page": 3,
    "field_label": "Burkitt lymphoma",
    "question": "Does the patient have Burkitt lymphoma?",
    "context": "Identifies Burkitt lymphoma as the specific B-cell lymphoma diagnosis."
  },
  "CB116": {
    "name": "CB116",
    "type": "checkbox",
    "page": 3,
    "field_label": "Diffuse large B-cell lymphoma",
    "question": "Does the patient have Diffuse large B-cell lymphoma?",
    "context": "Identifies diffuse large B-cell lymphoma as the specific B-cell lymphoma diagnosis."
  },
  "CB117": {
    "name": "CB117",
    "type": "checkbox",
    "page": 3,
    "field_label": "Follicular lymphoma",
    "question": "Does the patient have Follicular lymphoma?",
    "context": "Identifies follicular lymphoma as the specific B-cell lymphoma diagnosis."
  },
  "CB118": {
    "name": "CB118",
    "type": "checkbox",
    "page": 3,
    "field_label": "Gastric MALT lymphoma",
    "question": "Does the patient have Gastric MALT lymphoma?",
    "context": "Identifies gastric MALT lymphoma as the specific B-cell lymphoma diagnosis."
  },
  "CB119": {
    "name": "CB119",
    "type": "checkbox",
    "page": 3,
    "field_label": "High-grade B-Cell lymphoma",
    "question": "Does the patient have High-grade B-Cell lymphoma?",
    "context": "Identifies high-grade B-Cell lymphoma as the specific B-cell lymphoma diagnosis."
  },
  "CB120": {
    "name": "CB120",
    "type": "checkbox",
    "page": 3,
    "field_label": "Mantle cell lymphoma",
    "question": "Does the patient have Mantle cell lymphoma?",
    "context": "Identifies mantle cell lymphoma as the specific B-cell lymphoma diagnosis."
  },
  "CB121": {
    "name": "CB121",
    "type": "checkbox",
    "page": 3,
    "field_label": "Nodal marginal zone lymphoma",
    "question": "Does the patient have Nodal marginal zone lymphoma?",
    "context": "Identifies nodal marginal zone lymphoma as the specific B-cell lymphoma diagnosis."
  },
  "CB122": {
    "name": "CB122",
    "type": "checkbox",
    "page": 3,
    "field_label": "Nongastric MALT lymphoma",
    "question": "Does the patient have Nongastric MALT lymphoma?",
    "context": "Identifies nongastric MALT lymphoma as the specific B-cell lymphoma diagnosis."
  },
  "CB123": {
    "name": "CB123",
    "type": "checkbox",
    "page": 3,
    "field_label": "Primary cutaneous B-cell lymphomas",
    "question": "Does the patient have Primary cutaneous B-cell lymphomas?",
    "context": "Identifies primary cutaneous B-cell lymphomas as the specific B-cell lymphoma diagnosis."
  },
  "CB124": {
    "name": "CB124",
    "type": "checkbox",
    "page": 3,
    "field_label": "Splenic marginal zone lymphoma",
    "question": "Does the patient have Splenic marginal zone lymphoma?",
    "context": "Identifies splenic marginal zone lymphoma as the specific B-cell lymphoma diagnosis."
  },
  "CB125": {
    "name": "CB125",
    "type": "checkbox",
    "page": 3,
    "field_label": "Other:",
    "question": "Does the patient have an 'Other' type of B-cell lymphoma not listed?",
    "context": "Indicates if the patient's B-cell lymphoma diagnosis falls outside the provided categories."
  },
  "T126": {
    "name": "T126",
    "type": "text",
    "page": 3,
    "field_label": "Other:",
    "question": "Please specify the other type of B-cell lymphoma.",
    "context": "Text field to specify a B-cell lymphoma diagnosis not found in the predefined list."
  },
  "CB127": {
    "name": "CB127",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of multicentric Castleman's disease?",
    "context": "Primary question for Castleman's disease, confirming patient's diagnosis for treatment eligibility."
  },
  "CB128": {
    "name": "CB128",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Does the patient NOT have a documented diagnosis of multicentric Castleman's disease?",
    "context": "Primary question for Castleman's disease, confirming patient's diagnosis for treatment eligibility."
  },
  "CB129": {
    "name": "CB129",
    "type": "checkbox",
    "page": 4,
    "field_label": "leptomeningeal metastases from lymphoma",
    "question": "Does the patient's central nervous system lymphoma involve leptomeningeal metastases?",
    "context": "Sub-question for Central Nervous System Lymphomas, specifying disease manifestation for treatment protocol."
  },
  "CB130": {
    "name": "CB130",
    "type": "checkbox",
    "page": 4,
    "field_label": "primary CNS lymphoma",
    "question": "Does the patient have primary CNS lymphoma?",
    "context": "Sub-question for Central Nervous System Lymphomas, identifying the specific type of lymphoma."
  },
  "CB131": {
    "name": "CB131",
    "type": "checkbox",
    "page": 4,
    "field_label": "none of the above",
    "question": "Are none of the above central nervous system lymphoma types applicable to the patient?",
    "context": "Sub-question for Central Nervous System Lymphomas, indicating if patient's condition falls outside specified types."
  },
  "CB132": {
    "name": "CB132",
    "type": "checkbox",
    "page": 4,
    "field_label": "chronic lymphocytic leukemia (CLL)",
    "question": "Does the patient have chronic lymphocytic leukemia (CLL)?",
    "context": "Sub-question for Chronic or Small Lymphocytic Leukemia, specifying the leukemia type for treatment."
  },
  "CB133": {
    "name": "CB133",
    "type": "checkbox",
    "page": 4,
    "field_label": "small lymphocytic leukemia",
    "question": "Does the patient have small lymphocytic leukemia?",
    "context": "Sub-question for Chronic or Small Lymphocytic Leukemia, specifying the leukemia type for treatment."
  },
  "CB134": {
    "name": "CB134",
    "type": "checkbox",
    "page": 4,
    "field_label": "none of the above",
    "question": "Are none of the above chronic or small lymphocytic leukemia types applicable to the patient?",
    "context": "Sub-question for Chronic or Small Lymphocytic Leukemia, indicating if patient's condition falls outside specified types."
  },
  "CB135": {
    "name": "CB135",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of cryoglobulinemia?",
    "context": "Primary question for Cryoglobulinemia, confirming the patient's diagnosis for treatment eligibility."
  },
  "CB136": {
    "name": "CB136",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Does the patient NOT have a documented diagnosis of cryoglobulinemia?",
    "context": "Primary question for Cryoglobulinemia, confirming the patient's diagnosis for treatment eligibility."
  },
  "CB139": {
    "name": "CB139",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Is there clinical documentation that corticosteroids and other immunosuppressive agents were ineffective for cryoglobulinemia?",
    "context": "Follow-up question for Cryoglobulinemia, assessing prior treatment failure with conventional therapies."
  },
  "CB140": {
    "name": "CB140",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Is there NO clinical documentation that corticosteroids and other immunosuppressive agents were ineffective for cryoglobulinemia?",
    "context": "Follow-up question for Cryoglobulinemia, assessing prior treatment failure with conventional therapies."
  },
  "CB144": {
    "name": "CB144",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Is there documentation that Rituxan (rituximab) is being used as a last-resort treatment for chronic graft versus host disease (GVHD)?",
    "context": "Primary question for Chronic Graft Versus Host Disease, verifying Rituxan's role as a salvage therapy."
  },
  "CB145": {
    "name": "CB145",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Is there NO documentation that Rituxan (rituximab) is being used as a last-resort treatment for chronic graft versus host disease (GVHD)?",
    "context": "Primary question for Chronic Graft Versus Host Disease, verifying Rituxan's role as a salvage therapy."
  },
  "CB141": {
    "name": "CB141",
    "type": "checkbox",
    "page": 4,
    "field_label": "relapsed hairy cell leukemia",
    "question": "Does the patient have relapsed hairy cell leukemia?",
    "context": "Sub-question for Hairy Cell Leukemia, specifying if the disease has recurred after initial treatment."
  },
  "CB142": {
    "name": "CB142",
    "type": "checkbox",
    "page": 4,
    "field_label": "refractory hairy cell leukemia",
    "question": "Does the patient have refractory hairy cell leukemia?",
    "context": "Sub-question for Hairy Cell Leukemia, indicating if the disease is unresponsive to prior treatments."
  },
  "CB143": {
    "name": "CB143",
    "type": "checkbox",
    "page": 4,
    "field_label": "none of the above",
    "question": "Are none of the above hairy cell leukemia types applicable to the patient?",
    "context": "Sub-question for Hairy Cell Leukemia, indicating if patient's condition falls outside specified types."
  },
  "CB137": {
    "name": "CB137",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Is there documentation that Rituxan (rituximab) is being used for treatment or prevention of antibody-mediated rejection in heart or other solid organ transplant recipients?",
    "context": "Primary question for Heart and Solid Organ Transplant, confirming Rituxan's use for rejection management."
  },
  "CB146": {
    "name": "CB146",
    "type": "checkbox",
    "page": 4,
    "field_label": "heart transplant recipient",
    "question": "Is the patient a heart transplant recipient?",
    "context": "Sub-question for Heart and Solid Organ Transplant, specifying the type of organ transplant received by the patient."
  },
  "CB147": {
    "name": "CB147",
    "type": "checkbox",
    "page": 4,
    "field_label": "other solid organ transplant recipient",
    "question": "Is the patient an other solid organ transplant recipient?",
    "context": "Sub-question for Heart and Solid Organ Transplant, specifying the type of organ transplant received by the patient."
  },
  "CB138": {
    "name": "CB138",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Is there NO documentation that Rituxan (rituximab) is being used for treatment or prevention of antibody-mediated rejection in heart or other solid organ transplant recipients?",
    "context": "Primary question for Heart and Solid Organ Transplant, confirming Rituxan's use for rejection management."
  },
  "CB148": {
    "name": "CB148",
    "type": "checkbox",
    "page": 4,
    "field_label": "Bavencio (avelumab)",
    "question": "Did Bavencio (avelumab) cause the immune checkpoint-inhibitor related encephalitis?",
    "context": "Sub-question for Immune Checkpoint-Inhibitor Related Encephalitis, identifying the causative agent for diagnosis."
  },
  "CB149": {
    "name": "CB149",
    "type": "checkbox",
    "page": 4,
    "field_label": "Imfinzi (durvalumab)",
    "question": "Did Imfinzi (durvalumab) cause the immune checkpoint-inhibitor related encephalitis?",
    "context": "Sub-question for Immune Checkpoint-Inhibitor Related Encephalitis, identifying the causative agent for diagnosis."
  },
  "CB150": {
    "name": "CB150",
    "type": "checkbox",
    "page": 4,
    "field_label": "Keytruda (pembrolizumab)",
    "question": "Did Keytruda (pembrolizumab) cause the immune checkpoint-inhibitor related encephalitis?",
    "context": "Sub-question for Immune Checkpoint-Inhibitor Related Encephalitis, identifying the causative agent for diagnosis."
  },
  "CB151": {
    "name": "CB151",
    "type": "checkbox",
    "page": 4,
    "field_label": "Opdivo (nivolumab)",
    "question": "Did Opdivo (nivolumab) cause the immune checkpoint-inhibitor related encephalitis?",
    "context": "Sub-question for Immune Checkpoint-Inhibitor Related Encephalitis, identifying the causative agent for diagnosis."
  },
  "CB152": {
    "name": "CB152",
    "type": "checkbox",
    "page": 4,
    "field_label": "Tecentriq (atezolizumab)",
    "question": "Did Tecentriq (atezolizumab) cause the immune checkpoint-inhibitor related encephalitis?",
    "context": "Sub-question for Immune Checkpoint-Inhibitor Related Encephalitis, identifying the causative agent for diagnosis."
  },
  "CB153": {
    "name": "CB153",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yervoy (ipilimumab)",
    "question": "Did Yervoy (ipilimumab) cause the immune checkpoint-inhibitor related encephalitis?",
    "context": "Sub-question for Immune Checkpoint-Inhibitor Related Encephalitis, identifying the causative agent for diagnosis."
  },
  "CB154": {
    "name": "CB154",
    "type": "checkbox",
    "page": 4,
    "field_label": "Other:",
    "question": "Was an 'Other' immune checkpoint-inhibitor the cause of the encephalitis?",
    "context": "Sub-question for Immune Checkpoint-Inhibitor Related Encephalitis, allowing specification of other causative agents."
  },
  "T155": {
    "name": "T155",
    "type": "text",
    "page": 4,
    "field_label": "Other:",
    "question": "Please specify the 'Other' immune checkpoint-inhibitor that caused the encephalitis.",
    "context": "Text field to detail other specific immune checkpoint inhibitors not listed for encephalitis causation."
  },
  "CB156": {
    "name": "CB156",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of refractory immune or idiopathic thrombocytopenic purpura (ITP)?",
    "context": "Primary question for Immune or Idiopathic Thrombocytopenic Purpura, confirming diagnosis for treatment."
  },
  "CB158": {
    "name": "CB158",
    "type": "checkbox",
    "page": 4,
    "field_label": "refractory immune thrombocytopenic purpura",
    "question": "Does the patient have refractory immune thrombocytopenic purpura?",
    "context": "Sub-question for Immune or Idiopathic Thrombocytopenic Purpura, specifying if the ITP is unresponsive to prior treatment."
  },
  "CB159": {
    "name": "CB159",
    "type": "checkbox",
    "page": 4,
    "field_label": "idiopathic thrombocytopenic purpura (ITP)",
    "question": "Does the patient have idiopathic thrombocytopenic purpura (ITP)?",
    "context": "Sub-question for Immune or Idiopathic Thrombocytopenic Purpura, specifying the type of purpura."
  },
  "CB157": {
    "name": "CB157",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Does the patient NOT have a documented diagnosis of refractory immune or idiopathic thrombocytopenic purpura (ITP)?",
    "context": "Primary question for Immune or Idiopathic Thrombocytopenic Purpura, confirming diagnosis for treatment."
  },
  "CB160": {
    "name": "CB160",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Is Rituxan (rituximab) being used as rejection prophylaxis in sensitized kidney transplant recipients with donor specific antibodies?",
    "context": "Primary question for Kidney Transplant Rejection Prophylaxis, confirming Rituxan's use in high-risk patients."
  },
  "CB161": {
    "name": "CB161",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Is Rituxan (rituximab) NOT being used as rejection prophylaxis in sensitized kidney transplant recipients with donor specific antibodies?",
    "context": "Primary question for Kidney Transplant Rejection Prophylaxis, confirming Rituxan's use in high-risk patients."
  },
  "CB162": {
    "name": "CB162",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of lymphocyte-predominant Hodgkin's lymphoma?",
    "context": "Primary question for Lymphocyte-Predominant Hodgkin's Lymphoma, confirming diagnosis for treatment eligibility."
  },
  "CB163": {
    "name": "CB163",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Does the patient NOT have a documented diagnosis of lymphocyte-predominant Hodgkin's lymphoma?",
    "context": "Primary question for Lymphocyte-Predominant Hodgkin's Lymphoma, confirming diagnosis for treatment eligibility."
  },
  "CB164": {
    "name": "CB164",
    "type": "checkbox",
    "page": 4,
    "field_label": "Relapsing-remitting MS (RRMS)",
    "question": "Has the patient been diagnosed with Relapsing-remitting MS (RRMS)?",
    "context": "Sub-question for Multiple Sclerosis, specifying the patient's diagnosed MS type for treatment context."
  },
  "CB165": {
    "name": "CB165",
    "type": "checkbox",
    "page": 4,
    "field_label": "Secondary-progressive MS (SPMS)",
    "question": "Has the patient been diagnosed with Secondary-progressive MS (SPMS)?",
    "context": "Sub-question for Multiple Sclerosis, specifying the patient's diagnosed MS type for treatment context."
  },
  "CB166": {
    "name": "CB166",
    "type": "checkbox",
    "page": 4,
    "field_label": "Primary-progressive MS (PPMS)",
    "question": "Has the patient been diagnosed with Primary-progressive MS (PPMS)?",
    "context": "Sub-question for Multiple Sclerosis, specifying the patient's diagnosed MS type for treatment context."
  },
  "CB167": {
    "name": "CB167",
    "type": "checkbox",
    "page": 4,
    "field_label": "Progressive-relapsing MS (PRMS)",
    "question": "Has the patient been diagnosed with Progressive-relapsing MS (PRMS)?",
    "context": "Sub-question for Multiple Sclerosis, specifying the patient's diagnosed MS type for treatment context."
  },
  "CB168": {
    "name": "CB168",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Has the patient discontinued other medications used for treating MS (not including Ampyra)?",
    "context": "Follow-up question for Multiple Sclerosis, indicating prior treatment history and potential reasons for change."
  },
  "CB169": {
    "name": "CB169",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Has the patient NOT discontinued other medications used for treating MS (not including Ampyra)?",
    "context": "Follow-up question for Multiple Sclerosis, indicating prior treatment history and potential reasons for change."
  },
  "CB170": {
    "name": "CB170",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG)?",
    "context": "Primary question for Myasthenia Gravis (MuSK-MG), confirming diagnosis for treatment eligibility."
  },
  "CB172": {
    "name": "CB172",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Has the patient had an unsatisfactory response to initial immunotherapy for MuSK-MG?",
    "context": "Follow-up question for Myasthenia Gravis (MuSK-MG), assessing failure of first-line treatments."
  },
  "CB173": {
    "name": "CB173",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Has the patient NOT had an unsatisfactory response to initial immunotherapy for MuSK-MG?",
    "context": "Follow-up question for Myasthenia Gravis (MuSK-MG), assessing failure of first-line treatments."
  },
  "CB171": {
    "name": "CB171",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Does the patient NOT have a documented diagnosis of muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG)?",
    "context": "Primary question for Myasthenia Gravis (MuSK-MG), confirming diagnosis for treatment eligibility."
  },
  "CB174": {
    "name": "CB174",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of neuromyelitis optica (Devic's disease)?",
    "context": "Primary question for Neuromyelitis Optica (Devic's disease), confirming diagnosis for treatment eligibility."
  },
  "CB175": {
    "name": "CB175",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Does the patient NOT have a documented diagnosis of neuromyelitis optica (Devic's disease)?",
    "context": "Primary question for Neuromyelitis Optica (Devic's disease), confirming diagnosis for treatment eligibility."
  },
  "CB176": {
    "name": "CB176",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Was the treatment with at least one immunotherapy ineffective for neuromyelitis optica?",
    "context": "Follow-up question for Neuromyelitis Optica, assessing prior treatment failure with immunotherapy."
  },
  "CB177": {
    "name": "CB177",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Was the treatment with at least one immunotherapy NOT ineffective for neuromyelitis optica?",
    "context": "Follow-up question for Neuromyelitis Optica, assessing prior treatment failure with immunotherapy."
  },
  "CB178": {
    "name": "CB178",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of opsoclonus-myoclonus-ataxia (OMA) associated with neuroblastoma?",
    "context": "Primary question for Opsoclonus-Myoclonus-Ataxia, confirming diagnosis and association for treatment eligibility."
  },
  "CB179": {
    "name": "CB179",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Does the patient NOT have a documented diagnosis of opsoclonus-myoclonus-ataxia (OMA) associated with neuroblastoma?",
    "context": "Primary question for Opsoclonus-Myoclonus-Ataxia, confirming diagnosis and association for treatment eligibility."
  },
  "CB180": {
    "name": "CB180",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Is the patient refractory to steroids, chemotherapy, and intravenous immunoglobulins for OMA?",
    "context": "Follow-up question for Opsoclonus-Myoclonus-Ataxia, assessing failure of multiple prior treatment lines."
  },
  "T189": {
    "name": "T189",
    "type": "text",
    "page": 4,
    "field_label": "Medication:",
    "question": "What is the name of the first medication tried for OMA?",
    "context": "Details of prior medications used for Opsoclonus-Myoclonus-Ataxia, essential for demonstrating refractoriness."
  },
  "T190": {
    "name": "T190",
    "type": "text",
    "page": 4,
    "field_label": "Date: (MM)",
    "question": "What is the month the first medication was started for OMA?",
    "context": "Month of administration for the first prior medication used for OMA, indicating treatment timeline."
  },
  "T191": {
    "name": "T191",
    "type": "text",
    "page": 4,
    "field_label": "Date: (DD)",
    "question": "What is the day the first medication was started for OMA?",
    "context": "Day of administration for the first prior medication used for OMA, indicating treatment timeline."
  },
  "T192": {
    "name": "T192",
    "type": "text",
    "page": 4,
    "field_label": "Date: (YYYY)",
    "question": "What is the year the first medication was started for OMA?",
    "context": "Year of administration for the first prior medication used for OMA, indicating treatment timeline."
  },
  "T193": {
    "name": "T193",
    "type": "text",
    "page": 4,
    "field_label": "Date: (MM)",
    "question": "What is the month the first medication was ended for OMA?",
    "context": "Month of cessation for the first prior medication used for OMA, indicating treatment timeline."
  },
  "T194": {
    "name": "T194",
    "type": "text",
    "page": 4,
    "field_label": "Date: (DD)",
    "question": "What is the day the first medication was ended for OMA?",
    "context": "Day of cessation for the first prior medication used for OMA, indicating treatment timeline."
  },
  "T195": {
    "name": "T195",
    "type": "text",
    "page": 4,
    "field_label": "Date: (YYYY)",
    "question": "What is the year the first medication was ended for OMA?",
    "context": "Year of cessation for the first prior medication used for OMA, indicating treatment timeline."
  },
  "T196": {
    "name": "T196",
    "type": "text",
    "page": 4,
    "field_label": "Medication:",
    "question": "What is the name of the second medication tried for OMA?",
    "context": "Details of prior medications used for Opsoclonus-Myoclonus-Ataxia, essential for demonstrating refractoriness."
  },
  "T197": {
    "name": "T197",
    "type": "text",
    "page": 4,
    "field_label": "Date: (MM)",
    "question": "What is the month the second medication was started for OMA?",
    "context": "Month of administration for the second prior medication used for OMA, indicating treatment timeline."
  },
  "T198": {
    "name": "T198",
    "type": "text",
    "page": 4,
    "field_label": "Date: (DD)",
    "question": "What is the day the second medication was started for OMA?",
    "context": "Day of administration for the second prior medication used for OMA, indicating treatment timeline."
  },
  "T199": {
    "name": "T199",
    "type": "text",
    "page": 4,
    "field_label": "Date: (YYYY)",
    "question": "What is the year the second medication was started for OMA?",
    "context": "Year of administration for the second prior medication used for OMA, indicating treatment timeline."
  },
  "T200": {
    "name": "T200",
    "type": "text",
    "page": 4,
    "field_label": "Date: (MM)",
    "question": "What is the month the second medication was ended for OMA?",
    "context": "Month of cessation for the second prior medication used for OMA, indicating treatment timeline."
  },
  "T201": {
    "name": "T201",
    "type": "text",
    "page": 4,
    "field_label": "Date: (DD)",
    "question": "What is the day the second medication was ended for OMA?",
    "context": "Day of cessation for the second prior medication used for OMA, indicating treatment timeline."
  },
  "T202": {
    "name": "T202",
    "type": "text",
    "page": 4,
    "field_label": "Date: (YYYY)",
    "question": "What is the year the second medication was ended for OMA?",
    "context": "Year of cessation for the second prior medication used for OMA, indicating treatment timeline."
  },
  "CB181": {
    "name": "CB181",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Is the patient NOT refractory to steroids, chemotherapy, and intravenous immunoglobulins for OMA?",
    "context": "Follow-up question for Opsoclonus-Myoclonus-Ataxia, assessing failure of multiple prior treatment lines."
  },
  "CB203": {
    "name": "CB203",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Is Rituxan (rituximab) being used as treatment of post-transplant lymphoproliferative disorder?",
    "context": "Primary question for Post-transplant Lymphoproliferative Disorder, confirming Rituxan's use as treatment."
  },
  "CB204": {
    "name": "CB204",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Is Rituxan (rituximab) NOT being used as treatment of post-transplant lymphoproliferative disorder?",
    "context": "Primary question for Post-transplant Lymphoproliferative Disorder, confirming Rituxan's use as treatment."
  },
  "CB205": {
    "name": "CB205",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Is Rituxan (rituximab) being used as prophylaxis for Epstein-Barr virus (EBV) post-transplant lymphoproliferative disorder?",
    "context": "Follow-up question for Post-transplant Lymphoproliferative Disorder, confirming Rituxan's use for EBV prophylaxis."
  },
  "CB206": {
    "name": "CB206",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Is Rituxan (rituximab) NOT being used as prophylaxis for Epstein-Barr virus (EBV) post-transplant lymphoproliferative disorder?",
    "context": "Follow-up question for Post-transplant Lymphoproliferative Disorder, confirming Rituxan's use for EBV prophylaxis."
  },
  "CB207": {
    "name": "CB207",
    "type": "checkbox",
    "page": 5,
    "field_label": "Mild",
    "question": "Is the patient's rheumatoid arthritis considered mild?",
    "context": "Indicates the severity level of the patient's rheumatoid arthritis for treatment eligibility."
  },
  "CB208": {
    "name": "CB208",
    "type": "checkbox",
    "page": 5,
    "field_label": "Moderate",
    "question": "Is the patient's rheumatoid arthritis considered moderate?",
    "context": "Indicates the severity level of the patient's rheumatoid arthritis for treatment eligibility."
  },
  "CB209": {
    "name": "CB209",
    "type": "checkbox",
    "page": 5,
    "field_label": "Severe",
    "question": "Is the patient's rheumatoid arthritis considered severe?",
    "context": "Indicates the severity level of the patient's rheumatoid arthritis for treatment eligibility."
  },
  "CB210": {
    "name": "CB210",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Is there evidence that the disease is active?",
    "context": "Confirms active disease state of rheumatoid arthritis, crucial for justifying treatment initiation."
  },
  "CB211": {
    "name": "CB211",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Is there no evidence that the disease is active?",
    "context": "Indicates lack of active disease state of rheumatoid arthritis, may impact treatment approval."
  },
  "CB212": {
    "name": "CB212",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Will Rituxan (rituximab) be used in combination with methotrexate?",
    "context": "Determines if the requested drug will be part of a combination therapy for rheumatoid arthritis."
  },
  "CB213": {
    "name": "CB213",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Will Rituxan (rituximab) not be used in combination with methotrexate?",
    "context": "Indicates Rituxan will be used as monotherapy or with other agents for rheumatoid arthritis."
  },
  "CB214": {
    "name": "CB214",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Has treatment with methotrexate been ineffective, not tolerated or contraindicated?",
    "context": "Assesses the patient's response or tolerance to prior methotrexate therapy, a prerequisite for Rituxan."
  },
  "CB216": {
    "name": "CB216",
    "type": "checkbox",
    "page": 5,
    "field_label": "ineffective",
    "question": "Was methotrexate treatment ineffective?",
    "context": "Specifies the reason for methotrexate failure, indicating the drug did not achieve desired clinical outcome."
  },
  "CB217": {
    "name": "CB217",
    "type": "checkbox",
    "page": 5,
    "field_label": "not tolerated",
    "question": "Was methotrexate treatment not tolerated?",
    "context": "Specifies the reason for methotrexate failure, indicating patient experienced adverse effects."
  },
  "CB218": {
    "name": "CB218",
    "type": "checkbox",
    "page": 5,
    "field_label": "contraindicated",
    "question": "Was methotrexate treatment contraindicated?",
    "context": "Specifies the reason for methotrexate failure, indicating medical reasons prevented its use."
  },
  "CB215": {
    "name": "CB215",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Has treatment with methotrexate not been ineffective, not tolerated or contraindicated?",
    "context": "Indicates that methotrexate therapy was effective, tolerated, and not contraindicated."
  },
  "CB223": {
    "name": "CB223",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Was treatment with another conventional DMARD ineffective?",
    "context": "Assesses the patient's response to other prior conventional DMARDs, a prerequisite for Rituxan."
  },
  "CB225": {
    "name": "CB225",
    "type": "checkbox",
    "page": 5,
    "field_label": "azathioprine",
    "question": "Was azathioprine ineffective?",
    "context": "Indicates if azathioprine, a conventional DMARD, failed to control the patient's condition."
  },
  "CB226": {
    "name": "CB226",
    "type": "checkbox",
    "page": 5,
    "field_label": "cyclosporine",
    "question": "Was cyclosporine ineffective?",
    "context": "Indicates if cyclosporine, a conventional DMARD, failed to control the patient's condition."
  },
  "CB227": {
    "name": "CB227",
    "type": "checkbox",
    "page": 5,
    "field_label": "hydroxychloroquine",
    "question": "Was hydroxychloroquine ineffective?",
    "context": "Indicates if hydroxychloroquine, a conventional DMARD, failed to control the patient's condition."
  },
  "CB228": {
    "name": "CB228",
    "type": "checkbox",
    "page": 5,
    "field_label": "leflunomide",
    "question": "Was leflunomide ineffective?",
    "context": "Indicates if leflunomide, a conventional DMARD, failed to control the patient's condition."
  },
  "CB229": {
    "name": "CB229",
    "type": "checkbox",
    "page": 5,
    "field_label": "sulfasalazine",
    "question": "Was sulfasalazine ineffective?",
    "context": "Indicates if sulfasalazine, a conventional DMARD, failed to control the patient's condition."
  },
  "CB224": {
    "name": "CB224",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Was treatment with another conventional DMARD not ineffective?",
    "context": "Indicates that other conventional DMARD therapy was effective or tolerated."
  },
  "CB281": {
    "name": "CB281",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of Sjögren's syndrome?",
    "context": "Confirms the primary diagnosis for which Rituxan is being requested, supporting medical necessity."
  },
  "CB282": {
    "name": "CB282",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Does the patient not have a documented diagnosis of Sjögren's syndrome?",
    "context": "Indicates the absence of Sjögren's syndrome diagnosis, affecting treatment eligibility."
  },
  "CB283": {
    "name": "CB283",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Was treatment with corticosteroids and other immunosuppressive agents ineffective?",
    "context": "Evaluates prior therapy failure for Sjögren's syndrome, justifying advanced treatment like Rituxan."
  },
  "T285": {
    "name": "T285",
    "type": "text",
    "page": 5,
    "field_label": "Medication:",
    "question": "What is the name of the first corticosteroid or immunosuppressive agent used?",
    "context": "Details the specific prior medication used and its failure for Sjögren's syndrome management."
  },
  "T286": {
    "name": "T286",
    "type": "text",
    "page": 5,
    "field_label": "Date: (MM)",
    "question": "What is the month the first medication was started?",
    "context": "Month of administration for the first corticosteroid/immunosuppressive agent in Sjögren's syndrome."
  },
  "T287": {
    "name": "T287",
    "type": "text",
    "page": 5,
    "field_label": "Date: (DD)",
    "question": "What is the day the first medication was started?",
    "context": "Day of administration for the first corticosteroid/immunosuppressive agent in Sjögren's syndrome."
  },
  "T288": {
    "name": "T288",
    "type": "text",
    "page": 5,
    "field_label": "Date: (YYYY)",
    "question": "What is the year the first medication was started?",
    "context": "Year of administration for the first corticosteroid/immunosuppressive agent in Sjögren's syndrome."
  },
  "T289": {
    "name": "T289",
    "type": "text",
    "page": 5,
    "field_label": "Date: (MM)",
    "question": "What is the month the first medication was ended?",
    "context": "Month of cessation for the first corticosteroid/immunosuppressive agent in Sjögren's syndrome."
  },
  "T290": {
    "name": "T290",
    "type": "text",
    "page": 5,
    "field_label": "Date: (DD)",
    "question": "What is the day the first medication was ended?",
    "context": "Day of cessation for the first corticosteroid/immunosuppressive agent in Sjögren's syndrome."
  },
  "T291": {
    "name": "T291",
    "type": "text",
    "page": 5,
    "field_label": "Date: (YYYY)",
    "question": "What is the year the first medication was ended?",
    "context": "Year of cessation for the first corticosteroid/immunosuppressive agent in Sjögren's syndrome."
  },
  "T292": {
    "name": "T292",
    "type": "text",
    "page": 5,
    "field_label": "Medication:",
    "question": "What is the name of the second corticosteroid or immunosuppressive agent used?",
    "context": "Details the specific second prior medication used and its failure for Sjögren's syndrome management."
  },
  "T293": {
    "name": "T293",
    "type": "text",
    "page": 5,
    "field_label": "Date: (MM)",
    "question": "What is the month the second medication was started?",
    "context": "Month of administration for the second corticosteroid/immunosuppressive agent in Sjögren's syndrome."
  },
  "T294": {
    "name": "T294",
    "type": "text",
    "page": 5,
    "field_label": "Date: (DD)",
    "question": "What is the day the second medication was started?",
    "context": "Day of administration for the second corticosteroid/immunosuppressive agent in Sjögren's syndrome."
  },
  "T295": {
    "name": "T295",
    "type": "text",
    "page": 5,
    "field_label": "Date: (YYYY)",
    "question": "What is the year the second medication was started?",
    "context": "Year of administration for the second corticosteroid/immunosuppressive agent in Sjögren's syndrome."
  },
  "T296": {
    "name": "T296",
    "type": "text",
    "page": 5,
    "field_label": "Date: (MM)",
    "question": "What is the month the second medication was ended?",
    "context": "Month of cessation for the second corticosteroid/immunosuppressive agent in Sjögren's syndrome."
  },
  "T297": {
    "name": "T297",
    "type": "text",
    "page": 5,
    "field_label": "Date: (DD)",
    "question": "What is the day the second medication was ended?",
    "context": "Day of cessation for the second corticosteroid/immunosuppressive agent in Sjögren's syndrome."
  },
  "T298": {
    "name": "T298",
    "type": "text",
    "page": 5,
    "field_label": "Date: (YYYY)",
    "question": "What is the year the second medication was ended?",
    "context": "Year of cessation for the second corticosteroid/immunosuppressive agent in Sjögren's syndrome."
  },
  "CB284": {
    "name": "CB284",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Was treatment with corticosteroids and other immunosuppressive agents not ineffective?",
    "context": "Indicates prior corticosteroid/immunosuppressive therapy was effective or tolerated for Sjögren's syndrome."
  },
  "CB299": {
    "name": "CB299",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of refractory thrombotic thrombocytopenic purpura (TTP)?",
    "context": "Confirms diagnosis of refractory TTP, indicating the severity and need for specific treatment."
  },
  "CB300": {
    "name": "CB300",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Does the patient not have a documented diagnosis of refractory thrombotic thrombocytopenic purpura (TTP)?",
    "context": "Indicates absence of refractory TTP diagnosis, affecting treatment eligibility for Rituxan."
  },
  "CB301": {
    "name": "CB301",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of Waldenström macroglobulinemia?",
    "context": "Confirms diagnosis of Waldenström macroglobulinemia, essential for Rituxan coverage."
  },
  "CB302": {
    "name": "CB302",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Does the patient not have a documented diagnosis of Waldenström macroglobulinemia?",
    "context": "Indicates absence of Waldenström macroglobulinemia diagnosis, affecting treatment eligibility."
  },
  "CB303": {
    "name": "CB303",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Is this continuation request a result of the patient receiving samples of Rituxan (rituximab)?",
    "context": "Determines if the current request is for continued therapy after receiving Rituxan samples."
  },
  "CB304": {
    "name": "CB304",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Is this continuation request not a result of the patient receiving samples of Rituxan (rituximab)?",
    "context": "Indicates the continuation request is for other reasons, not post-sample use."
  },
  "T305": {
    "name": "T305",
    "type": "text",
    "page": 5,
    "field_label": "Please indicate the length of time on Rituxan (rituximab):",
    "question": "What is the total length of time the patient has been on Rituxan (rituximab)?",
    "context": "Provides duration of Rituxan therapy, crucial for assessing ongoing efficacy and safety for continuation requests."
  },
  "CB310": {
    "name": "CB310",
    "type": "checkbox",
    "page": 5,
    "field_label": "Mild",
    "question": "Was the severity of the disease at baseline (pretreatment with Rituxan (rituximab)) mild?",
    "context": "Assesses baseline rheumatoid arthritis severity to evaluate treatment effectiveness for continuation requests."
  },
  "CB311": {
    "name": "CB311",
    "type": "checkbox",
    "page": 5,
    "field_label": "Moderate",
    "question": "Was the severity of the disease at baseline (pretreatment with Rituxan (rituximab)) moderate?",
    "context": "Assesses baseline rheumatoid arthritis severity to evaluate treatment effectiveness for continuation requests."
  },
  "CB312": {
    "name": "CB312",
    "type": "checkbox",
    "page": 5,
    "field_label": "Severe",
    "question": "Was the severity of the disease at baseline (pretreatment with Rituxan (rituximab)) severe?",
    "context": "Assesses baseline rheumatoid arthritis severity to evaluate treatment effectiveness for continuation requests."
  },
  "CB306": {
    "name": "CB306",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Is there clinical documentation supporting disease stability?",
    "context": "Confirms clinical documentation showing stable disease for continued Rituxan therapy in rheumatoid arthritis."
  },
  "CB307": {
    "name": "CB307",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Is there no clinical documentation supporting disease stability?",
    "context": "Indicates lack of documentation for disease stability, potentially impacting Rituxan continuation for RA."
  },
  "CB308": {
    "name": "CB308",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Is there clinical documentation supporting disease improvement?",
    "context": "Confirms clinical documentation showing disease improvement for continued Rituxan therapy in rheumatoid arthritis."
  },
  "CB309": {
    "name": "CB309",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Is there no clinical documentation supporting disease improvement?",
    "context": "Indicates lack of documentation for disease improvement, potentially impacting Rituxan continuation for RA."
  },
  "CB313": {
    "name": "CB313",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Is there clinical documentation supporting disease stability?",
    "context": "Confirms clinical documentation showing stable disease for continued Rituxan therapy for other indications."
  },
  "CB314": {
    "name": "CB314",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Is there no clinical documentation supporting disease stability?",
    "context": "Indicates lack of documentation for disease stability, potentially impacting Rituxan continuation for other indications."
  },
  "CB315": {
    "name": "CB315",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Is there clinical documentation supporting disease improvement?",
    "context": "Confirms clinical documentation showing disease improvement for continued Rituxan therapy for other indications."
  },
  "CB316": {
    "name": "CB316",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Is there no clinical documentation supporting disease improvement?",
    "context": "Indicates lack of documentation for disease improvement, potentially impacting Rituxan continuation for other indications."
  },
  "T317": {
    "name": "T317",
    "type": "text",
    "page": 5,
    "field_label": "Date: (MM)",
    "question": "What is the month the request was completed?",
    "context": "Month of the date the prior authorization request form was signed by the prescriber."
  },
  "T318": {
    "name": "T318",
    "type": "text",
    "page": 5,
    "field_label": "Date: (DD)",
    "question": "What is the day the request was completed?",
    "context": "Day of the date the prior authorization request form was signed by the prescriber."
  },
  "T319": {
    "name": "T319",
    "type": "text",
    "page": 5,
    "field_label": "Date: (YYYY)",
    "question": "What is the year the request was completed?",
    "context": "Year of the date the prior authorization request form was signed by the prescriber."
  }
}